Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04126187 · ClinicalTrials.gov registry record
AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study
A clinical trial, sponsored by Gainesville Eye Associates.
- Completed
- Registry status
- 30
- Enrollment target
NCT04126187 is a clinical trial that has completed, run by Gainesville Eye Associates. The registered enrollment target is 30 participants.
The verdict
NCT04126187 has completed, sponsored by Gainesville Eye Associates.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The objective of this study is to assess the spectacle independence of patients receiving the AcrySof® Panoptix® Intraocular lens (IOL) after uneventful cataract surgery.
Interventions
- DEVICE Panoptix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-05-14 |
| Est. Completion | 2021-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04126187
The ClinicalTrials.gov registry entry for NCT04126187 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gainesville Eye Associates, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Panoptix is the first listed.
NCT04126187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04126187 about?
NCT04126187 is a clinical study titled "AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study". The objective of this study is to assess the spectacle independence of patients receiving the AcrySof® Panoptix® Intraocular lens (IOL) after uneventful cataract surgery.
What is the current status of trial NCT04126187?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2020-05-14. Estimated completion is 2021-03-30.
What interventions are being tested in trial NCT04126187?
The interventions under investigation include: Panoptix (DEVICE).
Who is sponsoring clinical trial NCT04126187?
This trial is sponsored by Gainesville Eye Associates, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.